607 related articles for article (PubMed ID: 32314850)
21. Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Rossi F; Tortora C; Argenziano M; Di Paola A; Punzo F
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471272
[TBL] [Abstract][Full Text] [Related]
22. Is a "Cytokine Storm" Relevant to COVID-19?
Sinha P; Matthay MA; Calfee CS
JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
[No Abstract] [Full Text] [Related]
23. Targeting Host Defense System and Rescuing Compromised Mitochondria to Increase Tolerance against Pathogens by Melatonin May Impact Outcome of Deadly Virus Infection Pertinent to COVID-19.
Tan DX; Hardeland R
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992875
[TBL] [Abstract][Full Text] [Related]
24. Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly?
Öztürk G; Akbulut KG; Güney Ş
Turk J Med Sci; 2020 Oct; 50(6):1504-1512. PubMed ID: 32777902
[TBL] [Abstract][Full Text] [Related]
25. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
[TBL] [Abstract][Full Text] [Related]
26. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.
Hou X; Zhang X; Wu X; Lu M; Wang D; Xu M; Wang H; Liang T; Dai J; Duan H; Xu Y; Yu X; Li Y
Mol Cell Proteomics; 2020 Nov; 19(11):1749-1759. PubMed ID: 32788344
[TBL] [Abstract][Full Text] [Related]
27. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
28. Type I Diabetes Pathoetiology and Pathophysiology: Roles of the Gut Microbiome, Pancreatic Cellular Interactions, and the 'Bystander' Activation of Memory CD8
Anderson G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834709
[TBL] [Abstract][Full Text] [Related]
29. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
30. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
Nowill AE; de Campos-Lima PO
J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 causes COVID-19-like disease in cynomolgus macaques.
Le Bras A
Lab Anim (NY); 2020 Jun; 49(6):174. PubMed ID: 32424314
[No Abstract] [Full Text] [Related]
32. Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides.
Anderson G
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614029
[TBL] [Abstract][Full Text] [Related]
33. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
Chen J; Kelley WJ; Goldstein DR
J Immunol; 2020 Jul; 205(2):313-320. PubMed ID: 32493812
[TBL] [Abstract][Full Text] [Related]
34. Neurotropism of SARS-CoV 2: Mechanisms and manifestations.
Conde Cardona G; Quintana Pájaro LD; Quintero Marzola ID; Ramos Villegas Y; Moscote Salazar LR
J Neurol Sci; 2020 May; 412():116824. PubMed ID: 32299010
[No Abstract] [Full Text] [Related]
35. Targeting Proteases for Treating COVID-19.
Luan B; Huynh T; Cheng X; Lan G; Wang HR
J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793
[TBL] [Abstract][Full Text] [Related]
36. Effects of altered photoperiod due to COVID-19 lockdown on pregnant women and their fetuses.
Bagci S; Sabir H; Müller A; Reiter RJ
Chronobiol Int; 2020 Jul; 37(7):961-973. PubMed ID: 32519912
[TBL] [Abstract][Full Text] [Related]
37. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
[TBL] [Abstract][Full Text] [Related]
38. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
39. Management of epigenomic networks entailed in coronavirus infections and COVID-19.
El Baba R; Herbein G
Clin Epigenetics; 2020 Aug; 12(1):118. PubMed ID: 32758273
[TBL] [Abstract][Full Text] [Related]
40. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
